Trial Profile
Phase II trial of S-1 plus Cetuximab combination chemotherapy for advanced recurrent/metastatic carcinoma of the oral cavity
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Carcinoma; Mouth neoplasm
- Focus Therapeutic Use
- 13 Oct 2016 New trial record